HMG – Human Menopausal Gonadotropin (FSH/LH Research Hormone)
Compound Name: Human Menopausal Gonadotropin (HMG)
Classification: Research Hormone – Gonadotropin Complex (FSH/LH)
Description:
Human Menopausal Gonadotropin (HMG) is a purified gonadotropin preparation containing follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity. In controlled laboratory research environments, HMG is widely studied for its role in endocrine signaling pathways related to gonadal regulation, hormone–receptor interactions, and reproductive axis modeling.
In research settings, HMG is frequently utilized to examine follicle-stimulating hormone–mediated pathways, testicular and ovarian signaling mechanisms, and interactions within the hypothalamic–pituitary–gonadal (HPG) axis. Due to its combined FSH and LH activity profile, HMG serves as a valuable research compound for studying gonadotropin-driven cellular responses, receptor activation dynamics, and hormone-regulated biological processes in in-vitro and biochemical model systems.
This compound is supplied in lyophilized (freeze-dried) powder form to support stability and consistency in controlled laboratory research applications.
Scientific References:
- Boeri L, Capogrosso P, Salonia A.,
Current Pharmaceutical Design, 2021; 27(24):2775–2783 –
Gonadotropin treatment and endocrine signaling in male hypogonadotropic hypogonadism
- Al-Inany HG, Abou-Setta AM, Aboulghar MA, Mansour RT, Serour GI.,
Gynecological Endocrinology, 2009; 25(6):372–378 –
Human menopausal gonadotropin and follicle-stimulating hormone activity in reproductive research models
- Howles CM.,
Molecular and Cellular Endocrinology, 2000; 161(1–2):25–30 –
Role of luteinizing hormone and follicle-stimulating hormone in reproductive endocrine signaling
Disclaimer:
For Laboratory Research Use Only (RUO).
Not for human consumption. Not for therapeutic, diagnostic, agricultural, or veterinary use.
